40 Under 40
+$60,802Ticket revenue above goal
+376.2%
Media Summit pharma attendance
2024 → 2025
+88.6%
Transform pharma attendance
2023–24 vs. 2025–26
2.95M
MM+M social impressions
Nov. 2024 – Sept. 2026
2026 / EVENT REVENUE PERFORMANCE
Audience growth.
Commercial impact.
Selected revenue results from the events I marketed, measured against ticket goals, entry targets, and budgeted revenue.
Transform
+$11,985Revenue increase year over year
Pinnacle
+$9,487.50Revenue above budgeted target
Women of Distinction
+$65,925Revenue above budgeted target
+$11,150Entry revenue above goal
MM+M Awards
+$35,720Ticket revenue over budget
+$16,934Entry revenue over budget
Each result uses its stated benchmark. Entry and overall revenue measures are shown separately and are not added together.
01 / SELECTED WORK
From strategy
to momentum.
Audience acquisition, event marketing, and digital growth across healthcare and media brands.
MM+M MEDIA SUMMIT / EVENT MARKETING
A stronger audience.
A bigger conversation.
Integrated audience acquisition for a priority pharmaceutical audience, connecting event positioning with targeted promotion and registration.
21 → 100PHARMA ATTENDEES / 2024 → 2025
View objectives & results
The challenge
Increase qualified pharmaceutical participation at MM+M Media Summit.
The outcome
Pharma attendance increased 376.2% year over year, from 21 in 2024 to 100 in 2025. The 2023–2024 baseline totaled 38 attendees.
2026 snapshot: 42 confirmed pharma attendees with one month of promotion remaining. This is an in-progress count, not final attendance.
PHARMA ATTENDANCE+376.2%
Year-over-year growth
TRANSFORM / AUDIENCE ACQUISITION
Growth that lasts
beyond one event.
Nearly doubled pharmaceutical participation across two consecutive event cycles through integrated audience acquisition and ongoing optimization.
79 → 149TOTAL PHARMA ATTENDEES / TWO-YEAR PERIODS
View objectives & results
The challenge
Build a larger, sustained pharmaceutical audience for Transform.
The outcome
2023–2024: 79 total attendees, averaging 39.5 annually. 2025–2026: 149 total, averaging 74.5 annually. That represents an 88.6% increase across equal two-year periods.
Attendance grew from 49 in 2024 to 74 in 2025 (+51.0%), then reached 75 in 2026.
2026 commercial result
Event revenue increased $11,985 year over year.
ANNUAL PHARMA ATTENDANCE+88.6%
492024
742025
752026
Growth vs. the two-year baseline